TrialJournal of the American Board of Family Medicine : JABFM2025

Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion.

Mihaela Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.